Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ye.N. Tolchennikova"'
Autor:
T.P. Borisova, Ye.N. Tolchennikova
Publikováno v:
Zdorovʹe Rebenka, Vol 8, Iss 5.48, Pp 39-43 (2013)
The purpose of research — to estimate the efficacy of repeated courses of antiviral and immunotropic therapy in children with hematuric form of chronic glomerulonephritis (HFCGN) and concomitant chronic Epstein — Barr viral infection (EBVI). 54 c
Externí odkaz:
https://doaj.org/article/be1d1b7987974bcb966b8da03993835f
Autor:
T.P. Borisova, Ye.N. Tolchennikova
Publikováno v:
Zdorovʹe Rebenka, Vol 8, Iss 3.46, Pp 78-82 (2013)
The purpose of research — to estimate the efficacy of complex antiviral and immunotropic therapy of chronic Epstein-Barr viral infection (EBVI) in children with hematuric form of chronic glomerulonephritis (HFCGN). 54 children with HFCGN and chroni
Externí odkaz:
https://doaj.org/article/a160b0daa8624d7883e602d1b9f62575
Autor:
Ye.N. Tolchennikova
Publikováno v:
Zdorovʹe Rebenka, Vol 0, Iss 8.43, Pp 77-80 (2012)
The purpose is to study the clinical laboratory features of hematuric form of chronic glomerulonephritis (HFCGN) in children with chronic Epstein — Barr virus infection (EBVI). 110 children with HFCGN at the age of 3–17 years were examined. For
Externí odkaz:
https://doaj.org/article/a40a27b477f64c75b70747b3126ebed6
Autor:
T.P. Borisova, Ye.N. Tolchennikova
Publikováno v:
CHILD`S HEALTH. :39-43
The purpose of research — to estimate the efficacy of repeated courses of antiviral and immunotropic therapy in children with hematuric form of chronic glomerulonephritis (HFCGN) and concomitant chronic Epstein — Barr viral infection (EBVI). 54 c
Autor:
Ye.N. Tolchennikova
Publikováno v:
CHILD`S HEALTH; № 8.43 (2012); 77-80
Здоров'я дитини-Zdorovʹe rebenka; № 8.43 (2012); 77-80
Здоровье ребенка-Zdorovʹe rebenka; № 8.43 (2012); 77-80
Здоров'я дитини-Zdorovʹe rebenka; № 8.43 (2012); 77-80
Здоровье ребенка-Zdorovʹe rebenka; № 8.43 (2012); 77-80
The purpose is to study the clinical laboratory features of hematuric form of chronic glomerulonephritis (HFCGN) in children with chronic Epstein — Barr virus infection (EBVI). 110 children with HFCGN at the age of 3–17 years were examined. For